Mycovibes Biotechsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2024-10-14
Share capital
10,000.00 PLN
Registered address
ul. Złota 7/1, 00-019 Warszawa, Poland
Electronic delivery address
AE:PL-38040-41409-RHISS-27
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Katarzyna Agnieszka Nowakage 51 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 200 | $2,701.24 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-12-07.
64 1020 1013 0000 0202 0546 9061- 59 1020 1013 0000 0402 0546 9053
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| KCRS.A. | $43,596,034.97 | kcrcro.com | ||
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com | ||
| Biorenomésp. z o.o. | – | biorenome.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-12 | Share capital increase (5,000.00 PLN → 10,000.00 PLN) | |
| 2025-05-12 | Name change (Orbitica → Mycovibes Biotech) | |
| 2025-05-12 | Switch to PKD 2025 (10 PKD 2007 codes → 7 PKD 2025 codes) | |
| 2024-10-14 | Entered in the register |
FAQ
Last updated: 2026-10-07